Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-23

Clinical Trial Update: Longitudinal Study of Outcomes Measures in ALS Trials

View source ↗

Summary

This update reports on a longitudinal study of outcome measures used in amyotrophic lateral sclerosis trials to evaluate and standardize how disease progression…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Amyotrophic Lateral Sclerosis | Status: COMPLETED